Investor Outlook: ETFs lean into cash flow, income and innovation [BNN Bloomberg (Canada)]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: BNN Bloomberg
Patent strength, free cash flow and alternative income strategies are emerging as key differentiators in ETF construction. BNN Bloomberg spoke with Sean O'Hara, president of Pacer ETFs, about how select ETF strategies are designed to capture growth, manage valuation risk and deliver income without sacrificing long-term upside. Key Takeaways Patent-based ETF strategies aim to capture innovation-driven growth while avoiding traditional sector-heavy international benchmarks. Free cash flow screening is increasingly used as an alternative measure of quality and value in equity portfolios. Momentum-led market leadership has raised valuation concerns, prompting renewed interest in profitable, cash-generating companies. Income-focused ETFs are evolving beyond covered-call strategies to preserve equity upside. Tax-efficient income structures can improve cash flow for long-term investors, though taxes are deferred rather than eliminated. Read the full transcript below: ANDREW
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca to acquire China rights for AbelZeta's CAR-T therapy [Yahoo! Finance]Yahoo! Finance
- AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca [Yahoo! Finance]Yahoo! Finance
- AstraZeneca (NASDAQ:AZN) had its "sell" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- What Makes AstraZeneca (AZN) a Strong Growing Company? [Yahoo! Finance]Yahoo! Finance
- AstraZeneca Spotlights 2025 Growth, 2026 Launch Wave and $80B 2030 Goal at JPM Conference [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 1/20/26 - Form 6-K
- 1/8/26 - Form 6-K
- 1/2/26 - Form 6-K
- AZN's page on the SEC website